Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 4:1:5.
doi: 10.3389/neuro.24.005.2009. eCollection 2010.

Microtubule depolymerization potentiates alpha-synuclein oligomerization

A Raquel Esteves  1 , Daniela M Arduíno, Russell H Swerdlow, Catarina R Oliveira, Sandra M Cardoso
Affiliations

Microtubule depolymerization potentiates alpha-synuclein oligomerization

A Raquel Esteves et al. Front Aging Neurosci. .

Abstract

Parkinson's disease (PD) is associated with perturbed mitochondria function and alpha-synuclein fibrillization. We evaluated potential mechanistic links between mitochondrial dysfunction and alpha-synuclein aggregation. We studied a PD cytoplasmic hybrid (cybrid) cell line in which platelet mitochondria from a PD subject were transferred to NT2 neuronal cells previously depleted of endogenous mitochondrial DNA. Compared to a control cybrid cell line, the PD line showed reduced ATP levels, an increased free/polymerized tubulin ratio, and alpha-synuclein oligomer accumulation. Taxol (which stabilizes microtubules) normalized the PD tubulin ratio and reduced alpha-synuclein oligomerization. A nexus exists between mitochondrial function, cytoskeleton homeostasis, and alpha-synuclein oligomerization. In our model, mitochondrial dysfunction triggers an increased free tubulin, which destabilizes the microtubular network and promotes alpha-synuclein oligomerization.

Keywords: ATP; Parkinson disease; alpha-synuclein; cybrids; mitochondria; tubulin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Protein oligomerization in PD cybrids. (A) A11 staining is greater in the PD cybrids. Bars, 10 μm. (B) A western blot of alpha-synuclein monomer and oligomers in the PD and CT cybrid lines. (C) Densitometry analysis of alpha-synuclein western blots showing the ratio between alpha-synuclein oligomer and monomer levels corrected for GAPDH. The ratio is increased in the PD cybrid line. (D) Ubiquitination densitometry analysis showed the PD cybrid cells had more ubiquitinated protein. **P < 0.01 and ***P < 0.001, significantly different when compared to the CT cybrid lines.
Figure 2
Figure 2
Tubulin alterations in the PD cybrid lines. (A) Tubulin immunocytochemistry reveals disruption of the microtubule network in the PD cybrid lines. (B) SDS-PAGE analysis shows that in the PD cybrids the free/polymerized tubulin ratio is elevated. (C) After correcting for GADPH content the PD cybrids free/polymerized tubulin ratio was elevated as compared to the control cybrid cell line. **P < 0.01, significantly different as compared to the CT cybrid lines. Bars, 10 μm.
Figure 3
Figure 3
Effects of taxol on tubulin and alpha synuclein. (A) SDS-PAGE showing the effect of 5 nM taxol on free/polymerized tubulin ratios. (B) Densitometry analysis indicated after correcting for GADPH content, 5 nM taxol reduced the free/polymerized tubulin ratio in the PD but not the CT cybrid cells. (C) PAGE showing the effect of 5 nM taxol on alpha-synuclein oligomer levels. (D) Densitometry analysis indicated 5 nM taxol reduced alpha synuclein oligomer levels in the PD cybrid cells. **P < 0.01, significantly different when compared to the untreated CT cybrid cells. #P < 0.05 and ##P < 0.01, significantly different as compared to the untreated PD cybrid line.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alim M. A., Hossain M. S., Arima K., Takeda K., Izumyama Y., Nakamura M., Kaji H., Shinoda T., Hisanaga S., Uéda K. (2002). Tubulin seeds alpha-synuclein fibril formation. J. Biol. Chem. 277, 2112–211710.1074/jbc.M102981200 - DOI - PubMed
    1. Cappeleti G., Surrey T., Maci R. (2005). The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilizing factor. FEBS Lett. 579, 4781–478610.1016/j.febslet.2005.07.058 - DOI - PubMed
    1. Cardoso S. M., Moreira P. I., Agostinho P., Pereira C., Oliveira C. R. (2005). Neurodegenerative pathway in Parkinson's disease: Therapeutical strategies. Curr. Drugs _targets CNS Neural. Disord. 4, 405–41910.2174/1568007054546072 - DOI - PubMed
    1. Cardoso S. M., Santana I., Swerdlow R. H., Oliveira C. R. (2004). Mitochondrial dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem. 89, 1417–142610.1111/j.1471-4159.2004.02438.x - DOI - PubMed
    1. Cassarino D. S., Fall C. P., Swerdlow R. H., Smith T. S., Halvorsen E. M., Miller S. W., Parks J. K., Parker W. D., Bennet J. P. (1997). Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362, 77–86 - PubMed

LinkOut - more resources

  NODES
twitter 2